I. 
1. 
BACKGROUND INFORMATION ON THE PROCEDURE 
Submission of the dossier 
The  company  Alcon  Laboratories  (UK)  Ltd  submitted  on  25  November  1998  an  application  for 
Marketing Authorisation to the European Agency for the Evaluation of Medicinal Products (EMEA) 
for  Azopt,  through  the  centralised  procedure.  After  agreement  by  the  CPMP  on  18  July  1996,  this 
medicinal product has been referred to Part B of the Annex to Council Regulation No (EEC) 2309/93 
of 22 July 1993. 
The Rapporteur and Co-Rapporteur appointed by the CPMP and the evaluation teams were: 
Rapporteur: 
Prof. J.F Olalla Marañon (until 21.10.1999) 
Dr. C. Avendaño (from 22.10.1999) 
Co-
Rapporteur: 
Dr. E. Abadie 
Licensing status: 
At  the  time  of  the  submission  Azopt  had  been  given  a  Marketing  Authorisation  in  6  countries, 
including the US. 
2. 
• 
• 
• 
• 
• 
• 
• 
Steps taken for the assessment of the product 
The procedure started on 18 December 1998. 
The  Rapporteur's  first  assessment  report  was  circulated  to  all  CPMP  Members  on  8  March 
1999.  The  Co-Rapporteur's  first  assessment  report  was  circulated  to  all  CPMP  Members  on  4 
March 1999. 
During the meeting on 20-22 April 1999 the CPMP agreed on the consolidated list of questions 
to be sent to the company. The final consolidated list of questions was sent to the company on 
23 April 1999. 
The  company  submitted  the  responses  to  the  consolidated  list  of  questions  on  7  September 
1999. 
The Rapporteur circulated the response assessment report on the company’s responses to the list 
of questions to all CPMP Members on 28 October 1999. 
During  the  meeting  on  16-18  November  1999  the  CPMP,  in  the  light  of  the  overall  data 
submitted  and  the  scientific  discussion  within  the  Committee,  issued  a  positive  opinion  for 
granting a Marketing Authorisation to Azopt on 18 November 1999. 
The  CPMP  opinions  were  forwarded,  in  all  official  languages  of  the  European  Union,  to  the 
European Commission, which adopted the corresponding Decisions on 9 March 2000. 
1/1 
EMEA 2004 
 
 
 
 
 
 
